share_log

SciBase Will Present at the Redeye Medtech Event on April 24th

SciBase Will Present at the Redeye Medtech Event on April 24th

SciBase 将于 4 月 24 日出席 Redeye Medtech 活动
PR Newswire ·  04/23 09:05

STOCKHOLM, April 23, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders will participate at the Redeye Medtech event.

斯德哥尔摩,2024 年 4 月 23 日 /PRNewswire/ — SciBase Holding AB(“SciBase”) (停止:SCIB),基于增强智能的皮肤病解决方案的领先开发商 将参加 Redeye Medtech 活动。

On April 24 at CET 9.50 CEO Pia Renaudin will present the latest developments in SciBase at Redeye. The presentation is live broadcasted and can be followed at where the replay and the presentations will be available afterwards.

首席执行官皮亚·雷诺丁将于4月24日在欧洲中欧标准时间9点50分在Redeye上介绍SciBase的最新进展。该演示是现场直播的,可以在以下网址观看 之后将提供重播和演示文稿。

For additional information, please contact:
Pia Renaudin, VD, tel. +46732069802, e-mail: [email protected]

欲了解更多信息,请联系:
Pia Renaudin,VD,电话 +46732069802,电子邮件:[email protected]

Certified Advisor (CA):

Vator Securities
Tel: +46 8 580 065 99
Email: [email protected]

认证顾问 (CA):

Vator 证券
电话:+46 8 580 065 99
电子邮件:[电子邮件保护]

About SciBase:

关于 SciBase:

SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.

SciBase 是一家全球医疗技术公司,专门从事皮肤病学的早期发现和预防。SciBase 开发并商业化了 Nevisense,这是一个独特的即时护理平台,它结合了人工智能(人工智能)和先进的 EIS 技术,可提高诊断准确性,确保积极的皮肤健康管理。

Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.

我们的承诺是最大限度地减少患者的痛苦,使临床医生能够通过及时的检测和干预来改善和挽救生命,并降低医疗成本。

Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.

SciBase建立在瑞典斯德哥尔摩卡罗林斯卡研究所20多年的研究基础上,是皮肤病学进步领域的领导者。

The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at . All press releases and financial reports can be found here:

该公司自2015年6月2日起在纳斯达克第一北方成长市场交易所上市。要了解更多,请访问。所有新闻稿和财务报告都可以在这里找到:

This information was brought to you by Cision

这些信息是由 Cision 带给你的

The following files are available for download:

以下文件可供下载:

Redeye presentation

Redeye 演示文稿

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发